These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16136476)

  • 1. Coartem (artemether-lumefantrine) in Africa: the beginning of the end?
    Hastings IM; Ward SA
    J Infect Dis; 2005 Oct; 192(7):1303-4; author reply 1304-5. PubMed ID: 16136476
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem).
    Sisowath C; Strömberg J; Mårtensson A; Msellem M; Obondo C; Björkman A; Gil JP
    J Infect Dis; 2005 Mar; 191(6):1014-7. PubMed ID: 15717281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa.
    Sisowath C; Ferreira PE; Bustamante LY; Dahlström S; Mårtensson A; Björkman A; Krishna S; Gil JP
    Trop Med Int Health; 2007 Jun; 12(6):736-42. PubMed ID: 17550470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artemether-lumefantrine: an option for malaria.
    Stover KR; King ST; Robinson J
    Ann Pharmacother; 2012 Apr; 46(4):567-77. PubMed ID: 22496476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coartemether (artemether and lumefantrine): an oral antimalarial drug.
    Wernsdorfer WH
    Expert Rev Anti Infect Ther; 2004 Apr; 2(2):181-96. PubMed ID: 15482185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria.
    Price RN; Uhlemann AC; van Vugt M; Brockman A; Hutagalung R; Nair S; Nash D; Singhasivanon P; Anderson TJ; Krishna S; White NJ; Nosten F
    Clin Infect Dis; 2006 Jun; 42(11):1570-7. PubMed ID: 16652314
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Sutherland CJ; Lansdell P; Sanders M; Muwanguzi J; van Schalkwyk DA; Kaur H; Nolder D; Tucker J; Bennett HM; Otto TD; Berriman M; Patel TA; Lynn R; Gkrania-Klotsas E; Chiodini PL
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28137810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria.
    Tchaparian E; Sambol NC; Arinaitwe E; McCormack SA; Bigira V; Wanzira H; Muhindo M; Creek DJ; Sukumar N; Blessborn D; Tappero JW; Kakuru A; Bergqvist Y; Aweeka FT; Parikh S
    J Infect Dis; 2016 Oct; 214(8):1243-51. PubMed ID: 27471317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coartem(®): a decade of patient-centric malaria management.
    Hamed K; Grueninger H
    Expert Rev Anti Infect Ther; 2012 Jun; 10(6):645-59. PubMed ID: 22554131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. West Africa International Centers of Excellence for Malaria Research: Drug Resistance Patterns to Artemether-Lumefantrine in Senegal, Mali, and The Gambia.
    Dieye B; Affara M; Sangare L; Joof F; Ndiaye YD; Gomis JF; Ndiaye M; Mbaye A; Diakite M; Sy N; Mbengue B; Deme AB; Daniels R; Ahouidi AD; Dieye T; Abdullahi A; Doumbia S; Ndiaye JL; Diarra A; Ismaela A; Coulibaly M; Welty C; Ngwa AA; Shaffer J; D'Alessandro U; Volkman SK; Wirth DF; Krogstad DJ; Koita O; Nwakanma D; Ndiaye D
    Am J Trop Med Hyg; 2016 Nov; 95(5):1054-1060. PubMed ID: 27549635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of in vivo selection for K13 mutations after artemether-lumefantrine treatment in Uganda.
    Balikagala B; Mita T; Ikeda M; Sakurai M; Yatsushiro S; Takahashi N; Tachibana SI; Auma M; Ntege EH; Ito D; Takashima E; Palacpac NM; Egwang TG; Onen JO; Kataoka M; Kimura E; Horii T; Tsuboi T
    Malar J; 2017 Jan; 16(1):23. PubMed ID: 28068997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acute uncomplicated falciparum malaria with artemether-lumefantrine in nonimmune populations: a safety, efficacy, and pharmacokinetic study.
    Hatz C; Soto J; Nothdurft HD; Zoller T; Weitzel T; Loutan L; Bricaire F; Gay F; Burchard GD; Andriano K; Lefèvre G; De Palacios PI; Genton B
    Am J Trop Med Hyg; 2008 Feb; 78(2):241-7. PubMed ID: 18256423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.
    Thomsen TT; Ishengoma DS; Mmbando BP; Lusingu JP; Vestergaard LS; Theander TG; Lemnge MM; Bygbjerg IC; Alifrangis M
    Am J Trop Med Hyg; 2011 Dec; 85(6):979-83. PubMed ID: 22144430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
    Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
    Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
    Tarning J; McGready R; Lindegardh N; Ashley EA; Pimanpanarak M; Kamanikom B; Annerberg A; Day NP; Stepniewska K; Singhasivanon P; White NJ; Nosten F
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3837-46. PubMed ID: 19564366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with coartem (artemether-lumefantrine) in Papua New Guinea.
    Schoepflin S; Lin E; Kiniboro B; DaRe JT; Mehlotra RK; Zimmerman PA; Mueller I; Felger I
    Am J Trop Med Hyg; 2010 Apr; 82(4):529-34. PubMed ID: 20348494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pfmdr1 mutations in imported African Plasmodium falciparum isolates.
    Dippmann AK; Bienzle U; Harms G; Mockenhaupt FP
    Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1148-50. PubMed ID: 18513774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda.
    Nsobya SL; Dokomajilar C; Joloba M; Dorsey G; Rosenthal PJ
    Antimicrob Agents Chemother; 2007 Aug; 51(8):3023-5. PubMed ID: 17562798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artemether-lumefantrine (Coartem) for treatment of malaria.
    Med Lett Drugs Ther; 2009 Sep; 51(1321):75-6. PubMed ID: 19763049
    [No Abstract]   [Full Text] [Related]  

  • 20. The MSPDBL2 codon 591 polymorphism is associated with lumefantrine in vitro drug responses in Plasmodium falciparum isolates from Kilifi, Kenya.
    Ochola-Oyier LI; Okombo J; Mwai L; Kiara SM; Pole L; Tetteh KK; Nzila A; Marsh K
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1770-5. PubMed ID: 25534732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.